Skip to Content

Peginterferon Alfa 2-b



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Therapeutic Categories

Antiviral agent: Treatment of hepatitis

Biological response modifier, BRM


Chemical Name

Monocarboxyinterferon alfa-2b, diesters wit polyetylene glycol monometyl eter (WHO)

Foreign Names

  • Peginterferonum alfa-2b (Latin)
  • Peginterferon alfa 2-b (German)
  • Peginterf√©ron alfa 2-b (French)
  • Peginterfer√≥n alfa 2-b (Spanish)

Generic Names

Brand Names

  • Cylatron
    Merck Sharp & Dohme, Chile; Merck Sharp & Dohme, Colombia; MSD, Switzerland
  • Egyferon
    Nile, Egypt
  • Intron A Peg
    Schering-Plough, Argentina
  • Peg Intron
    Schering-Plough, Indonesia; Scherring, Egypt
  • Pegasys
    Roche, Greece
  • Pegatron Combination Therapy
    Schering-Plough, Australia
  • Pegatron Combination Therapy (Peginterferon Alfa 2-b and Ribavirin)
    Merck Sharp & Dohme, New Zealand
  • Pegetron (Peginterferon Alfa 2-b and Ribavirin)
    Merck, Canada
  • PegIntron
    Merck Sharp & Dohme, Austria; Merck Sharp & Dohme, Bosnia & Herzegowina; Merck Sharp & Dohme, Greece; Merck Sharp & Dohme, Iceland; Merck Sharp & Dohme, Lithuania; Merck Sharp & Dohme, Poland; Merck Sharp & Dohme, Romania; MSD, Switzerland; MSD, Denmark; MSD, Finland; MSD, Japan; MSD, Netherlands; MSD, Norway; MSD, Peru; MSD, Sweden; MSD Belgium, Belgium; MSD Merck Sharp & Dohme, Germany; MSD Merck Sharp & Dohme, Turkey; MSD Pharma, Hungary; Schering, United States; Schering-Plough, Czech Republic; Schering-Plough, Georgia; Schering-Plough, Croatia (Hrvatska); Schering-Plough, Israel; Schering-Plough, Italy; Schering-Plough, Latvia; Schering-Plough, Serbia; Schering-Plough, Slovakia; Schering-Plough, Vietnam; Schering-Plough, South Africa
  • Pegintron
    Merck Sharp & Dohme, Spain
  • Peg-Intron
    Merck Sharp & Dohme, Australia; Merck Sharp & Dohme, Chile; Merck Sharp & Dohme, Colombia; Merck Sharp & Dohme, Hong Kong; Merck Sharp & Dohme, Malaysia; MSD, China; MSD, Myanmar; MSD, Thailand; Schering-Plough, Philippines; Schering-Plough, Taiwan
  • Pegtron
    Schering-Plough, Mexico
  • Sylatron
    Schering, United States
  • Victrelis Triple (Peginterferon Alfa 2-b and Boceprevir, + Ribavirin)
    Merck, Canada
  • Viraferonpeg
    Merck Sharp & Dohme, Croatia (Hrvatska); Merck Sharp & Dohme, Poland; Merck Sharp & Dohme, Tunisia; MSD, Ireland; Schering-Plough, Lithuania
  • ViraferonPeg
    Merck Sharp & Dohme, United Kingdom


BANBritish Approved Name
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.